𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Aciclovir or ganciclovir universal prophylaxis of cytomegalovirus infection in liver transplantation: an economic analysis

✍ Scribed by R. W. L. Leong; D. W. Smith; G. Garas; J. M. Beaman; A. W. Mitchell; D. I. Heath; A. K. House; G. P. Jeffrey

Book ID
109001333
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
181 KB
Volume
34
Category
Article
ISSN
1444-0903

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Increased incidence of cytomegalovirus i
Increased incidence of cytomegalovirus infection in high-risk liver transplant recipients receiving valganciclovir prophylaxis versus ganciclovir prophylaxis
✍ Kevin T. Shiley; Leanne B. Gasink; Todd D. Barton; Patrice Pfeiffenberger; Kim M πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 83 KB πŸ‘ 1 views

Optimal measures for the prevention of cytomegalovirus (CMV) in high-risk orthotopic liver transplant (OLT) patients are unknown. The charts of high-risk OLT recipients with 12 months of follow-up who were transplanted over a 44-month period were reviewed. The incidence of CMV disease in CMV-seropos

Analysis of cytomegalovirus DNA polymera
Analysis of cytomegalovirus DNA polymerase (UL54) mutations in solid organ transplant patients receiving valganciclovir or ganciclovir prophylaxis
✍ Guy Boivin; Nathalie Goyette; Christian Gilbert; Emma Covington πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 65 KB

## Abstract We previously reported the absence of CMV __UL97__ (kinase) gene resistance mutations up to 12 months post‐transplant following 100 days of valganciclovir prophylaxis, and a low incidence of resistance mutations following 100 days of oral ganciclovir prophylaxis in a prospective multice